StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)

Close on Nov 18, 2026Market cap $53.09MP/E –Yield –

Corbus Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Corbus Pharmaceuticals's total debt was $12.76M at Mar 31, 2024. For fiscal 2023 it was $15.91M, down 15.3% from the year before. The highest annual figure on record is $18.78M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$15.91M-15.3%
FY2022Dec 31, 2022$18.78M+0.3%
FY2021Dec 31, 2021$18.73M+3.9%
FY2020Dec 31, 2020$18.03M–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$331.24K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$12.76M-32.7%
Q4 FY2023Dec 31, 2023$15.91M-15.3%
Q3 FY2023Sep 30, 2023$17.85M-7.4%
Q2 FY2023Jun 30, 2023$18.34M-3.9%
Q1 FY2023Mar 31, 2023$18.98M+0.4%
Q4 FY2022Dec 31, 2022$18.78M+0.3%
Q3 FY2022Sep 30, 2022$19.27M+3.9%
Q2 FY2022Jun 30, 2022$19.09M+3.9%
Q1 FY2022Mar 31, 2022$18.91M+3.9%
Q4 FY2021Dec 31, 2021$18.73M+3.9%
Q3 FY2021Sep 30, 2021$18.55M+3.9%
Q2 FY2021Jun 30, 2021$18.37M–
Q1 FY2021Mar 31, 2021$18.20M–
Q4 FY2020Dec 31, 2020$18.03M–
Q3 FY2020Sep 30, 2020$17.86M–

More Corbus Pharmaceuticals figures

See a number that looks wrong?